Fluticasone propionate 250 mcg/INHAL Dry Powder Inhaler, 60 Blisters
RxNorm 896025

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 896025 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fluticasone propionate 250 mcg/INHAL Dry Powder Inhaler, 60 Blisters.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
60 ACTUAT fluticasone propionate 0.25 mg/ACTUAT Dry Powder Inhaler
Primary clinical definition
AUI:12330976
View
SY
Fluticasone propionate 0.25 mg/ACTUAT Dry Powder Inhaler, 60 ACTUAT
AUI:3051639
View
PSN
Fluticasone propionate 250 mcg/INHAL Dry Powder Inhaler, 60 Blisters
AUI:6358915
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
60 ACTUAT fluticasone propionate 0.25 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 12330976)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT Dry Powder Inhaler
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
896025
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12330976
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
896025
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{896024} 50121
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{896024} 41126
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.25 MG/ACTUAT
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{896024} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN QUANTITY
60 ACTUAT
Normal Form quantity factor
RXTERM FORM
DPI
The RxTerm dose form name for this drug
SYPrescribable

Synonym (SY):
Fluticasone propionate 0.25 mg/ACTUAT Dry Powder Inhaler, 60 ACTUAT
(Atom ID: 3051639)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
fluticasone propionate 0.25 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
896025
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3051639
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
896025
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSNPrescribable

Prescribable Name (PSN):
Fluticasone propionate 250 mcg/INHAL Dry Powder Inhaler, 60 Blisters
(Atom ID: 6358915)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
fluticasone propionate 250 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
896025
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6358915
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
896025
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Fluticasone Oral Inhalation


Fluticasone oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children. It is in a class of medications called corticosteroids. Fluticasone works by decreasing swelling and irritation in the airways to allow for easier breathing.
[Learn More]


* Please review the disclaimer below.